Years of Life Lost (YLLs) due to drug-related deaths in the Islamic Republic Of Iran (2014-2017): a temporal and geographic pattern

Alipour, Abbas; Babakhanian, Masoudeh; Zarghami, Mehran; Khosravi, Ardeshir; Saberi, Mehdi

doi:10.1590/1413-81232022277.23252021

Cited by 3 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is no geographical variability in antinarcotic law in Iran. However, it is consistent with other studies in terms of resource limitations and deaths due to the consumption of these substances [ 94 ].…”

Section: Discussionsupporting

confidence: 92%

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis

Razavi-Amoli

Alipour

2022

Open Forum Infectious Diseases

View full text Add to dashboard Cite

HCV co-infection is associated with higher mortality and morbidity in people with HIV (PWH). We aimed to characterize the epidemiology and factors associated with HCV co-infection among PWH in Iran. In this systematic review, we searched three English databases (MEDLINE, SCOPUS, Embase) and two Farsi databases (Scientific Information Database, and Magiran) for studies that measured the prevalence of HCV co-infection among PWH, published between 2000 and January 1, 2021. We included studies with a minimum sample size of 5 PWH. Reviews, editorials, conference abstracts, theses, studies with no relevant data, and unclear serological assays were excluded. We summarized the HCV co-infection prevalence by random-effect meta-analysis and assessed the sources of heterogeneity by a meta-regression model. Of the 858 records identified, 69 eligible studies with 12996 PWH were included. Overall, HCV co-infection prevalence was 64% (95%CI 58–69). The prevalence was higher among older (mean age >= 35y) PWH (69%, 95%CI 64-74), and PWH who inject drugs (77%, 95%CI 71-82). Furthermore, we found that co-infection was higher among studies conducted between 2000-2014 (67%, 95%CI 59-75) versus 2015-2020 (57%, 95%CI 50-64). The prevalence of HCV co-infection is high in Iranian PWH, with significant geographical variations. HCV screening and treatment among PWH are warranted to avoid the future burden of HCV-related liver damage, cancer, and mortality.

show abstract

Section: Discussionsupporting

confidence: 92%

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis

Razavi-Amoli

Alipour

2022

Open Forum Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…To explain rates of drug poisoning in the Semnan province and the apparent paradox of rates in this province, we examined two factors (spatial and time trend) affecting drug poisoning using spatial methods. Although recent studies have linked high elevations with increased death related drug use (10,11), intentional or unintentional Drug intoxication all of which influence drug poisoning rates.…”

Section: Literature Reviewmentioning

confidence: 99%

Temporal Trend and Spatial Distribution of Drug Poisoning in Semnan Province: A Retrospective Longitudinal Study

Babakhanian

Mamashli

Ansariniya

et al. 2022

Middle East J Rehabil Health Stud

Self Cite

View full text Add to dashboard Cite

Background: Substance abuse and the risks of its consequences are the major public health problems in the world and Iran. Objectives: The objective of the present study is determination the epidemiological status and spatial distribution of high-risk and low-risk clusters along with estimating the relative risk of drug poisoning in Semnan in 8 years. Methods: A descriptive-analytical and retrospective longitudinal study was conducted that examined all 3360 poisoned patients who referred to the hospitals of Semnan province from 2011 - 2018. The total number of visits was received and analyzed by year with the relevant diagnostic code in ICD-10 from hospitals of the province, and data were analyzed using Joinpoint regression analysis, global Moran’s index and Kuldorff's spatial statistic scan at a significant level of 0.05. Results: The number of clients varied from 219 in 2011 to 570 in 2015. The patients' mean age was 26.7 years. The average annual number of cases per one hundred thousand individuals (annual cases/100000) was 598.4. The AAPC of the incidence of drug poisoning was 9.8 and significant in the whole province, demonstrating that the incidence of poisoning increased by an average of 9.8% per year in the whole province from 2011 to 2018. Semnan County with LLR = 533.07 was the most likely low-risk cluster, and Shahroud County was the most likely high-risk cluster with LLR = 219.94. Conclusions: Drug policies need to be adapted to the geographical differences in the place death. After clustering regions in poisoning incidents, the necessary interventions can be concentrated for these specific geographical locations.

show abstract

Years of Life Lost Due to Complete Suicide in Iran: A National Registry-Based Study

Rostami,

Jalilian,

Jalilian

et al. 2024

J Res Health Sci

View full text Add to dashboard Cite

Background: Suicide was the fourth leading cause of death among individuals aged 15 to 29 years worldwide in 2019, highlighting its significant impact on young people. Iran’s suicide-related mortality rate was 5.1 per 100000 population in the same year, which is lower than the global average. This study aimed to estimate the years of life lost (YLLs) due to complete suicide in Iran. Study Design: A registry-based cross-sectional study. Methods: The data on complete suicide cases used in this study were obtained from the national suicide registry of the Iranian Forensic Medicine Organization (FMO) that was registered between March 21, 2016 and March 20, 2020. Results: The total number of YLL due to premature death by suicide over the four-year period was 611068 years (15.97 per 1000 persons) in males, 286847 years (7.65 per 1000 persons) in females, and 897915 years (11.86 per 1000 persons) for both genders. Moreover, the age group of 15–29 years experienced the highest YLL attributed to suicide. Furthermore, the study revealed an increasing trend of YLL due to suicide among individuals aged 30–44. Conclusion: These findings highlight the significant impact of suicide on the loss of potential years of life in Iran. The study indicates that the young and productive age groups of 15-29 and 30-44 years are particularly affected, with the highest YLL due to complete suicide. The study provides valuable insights for designing targeted and evidence-based suicide prevention programs that can reduce the burden of suicide in Iran, particularly among young and middle-aged adults.

show abstract

Years of Life Lost (YLLs) due to drug-related deaths in the Islamic Republic Of Iran (2014-2017): a temporal and geographic pattern

Cited by 3 publications

References 24 publications

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis

Temporal Trend and Spatial Distribution of Drug Poisoning in Semnan Province: A Retrospective Longitudinal Study

Years of Life Lost Due to Complete Suicide in Iran: A National Registry-Based Study

Contact Info

Product

Resources

About